| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016PLoSO..1168907S |
| P356 | DOI | 10.1371/JOURNAL.PONE.0168907 |
| P932 | PMC publication ID | 5201247 |
| P698 | PubMed publication ID | 28036362 |
| P50 | author | Limin Zheng | Q51196796 |
| Hong-Wei Sun | Q59685286 | ||
| P2093 | author name string | Jing Chen | |
| Jing Xu | |||
| Ming Shi | |||
| Wen-Chao Wu | |||
| Xing-Juan Yu | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| T cell metabolism drives immunity | Q26799575 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| Glucose transporters in the 21st Century | Q29302398 | ||
| Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma | Q33820376 | ||
| The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function | Q33838591 | ||
| Upregulated SLC1A5 promotes cell growth and survival in colorectal cancer | Q34371526 | ||
| Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response | Q34375447 | ||
| Expression characteristics of hypoxia-inducible factor-1α and its clinical values in diagnosis and prognosis of hepatocellular carcinoma | Q35603807 | ||
| Overexpression of GLUT1 in colorectal cancer is independently associated with poor prognosis. | Q54357692 | ||
| Erratum: Advances in targeted therapies for hepatocellular carcinoma in the genomic era | Q57756427 | ||
| Nutrient Competition: A New Axis of Tumor Immunosuppression | Q86113118 | ||
| Focus on hepatocellular carcinoma. | Q35721877 | ||
| Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses. | Q36054460 | ||
| CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma. | Q36210826 | ||
| High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma | Q36310209 | ||
| Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. | Q36386431 | ||
| The transport of glutamine into mammalian cells | Q36664452 | ||
| Lactate promotes glutamine uptake and metabolism in oxidative cancer cells | Q36781200 | ||
| SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival | Q36968924 | ||
| ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. | Q37023688 | ||
| ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer | Q37711691 | ||
| Targeting cancer metabolism: a therapeutic window opens | Q37924094 | ||
| A colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarrays | Q39559166 | ||
| miR-132 mediates a metabolic shift in prostate cancer cells by targeting Glut1. | Q39615767 | ||
| GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis | Q39872802 | ||
| Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation | Q40484358 | ||
| Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells | Q40697307 | ||
| Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells | Q41427795 | ||
| Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression | Q41437712 | ||
| Glucose availability regulates IFN-gamma production and p70S6 kinase activation in CD8+ effector T cells | Q42476602 | ||
| GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. | Q42493452 | ||
| GLUT1 Messenger RNA and Protein Induction Relates to the Malignant Transformation of Cervical Cancer | Q44649612 | ||
| An in situ molecular signature to predict early recurrence in hepatitis B virus-related hepatocellular carcinoma. | Q45358181 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | e0168907 | |
| P577 | publication date | 2016-12-30 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma | |
| P478 | volume | 11 |
| Q36412474 | A biosystems approach to identify the molecular signaling mechanisms of TMEM30A during tumor migration. |
| Q41573099 | Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer |
| Q38697504 | E-cadherin expression increases cell proliferation by regulating energy metabolism through nuclear factor-κB in AGS cells. |
| Q92610269 | GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome |
| Q90618703 | Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin β1/Src/FAK Signaling |
| Q57174877 | Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2 |
| Q88761261 | Lipid metabolism reprogramming and its potential targets in cancer |
| Q91013912 | Metabolic rearrangements in primary liver cancers: cause and consequences |
| Q89454724 | The critical role of glucose deprivation in epithelial-mesenchymal transition in hepatocellular carcinoma under hypoxia |
Search more.